News
Needham raises Google (GOOGL) price target to $210, citing strong corporate culture, GenAI leadership, and strategic ...
Li Auto faces a headwind with the suspended EV trade-in subsidy already triggering demand headwinds in early July 2025. Read ...
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...
Nasus Pharma has filed to raise $11M in an IPO of its ordinary shares, according to SEC F-1 registration. Read why my outlook ...
The Fed's structure and upcoming appointments make a dovish policy shift likely. What will happen if Trump gets his 300bps ...
Pershing Square, led by Bill Ackman, recently acquired a big stake in Howard Hughes at a significant premium, signaling ...
Palantir ( NASDAQ: PLTR) was upgraded to Neutral from Underperform by Mizuho Securities as its sustained revenue growth has ...
Bitcoin's rise, driven by speculation and subprime financing, risks retail investors as ETFs reshape its purpose. Read more ...
Kraft Heinz's struggles since the 2015 merger, including brand write-downs and declining sales, have eroded shareholder value ...
Goldman’s main bullish case for gold centers on continued strong central bank and institutional buying. Click to read.
Novartis (NVS) stock slips as the company lost its bid to block MSN Pharma's generic Entresto launch after a U.S. judge ruled against its injunction. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results